Afficher la notice abrégée

Towards the lowest efficacious dose (toledo): results of a multicenter non-inferiority randomized open-label controlled trial assessing tocilizumab or abatacept injection spacing in rheumatoid arthritis patients in remission

dc.rights.licenseopenen_US
dc.contributor.authorJOANNA, Kedra
dc.contributor.authorDIEUDE, Philippe
dc.contributor.authorMAROTTE, Hubert
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorLAFOURCADE, Alexandre
dc.contributor.authorDUCOURAU, Emilie
dc.contributor.authorSCHAEVERBEKE, Thierry
dc.contributor.authorPERDRIGER, Aleth
dc.contributor.authorSOUBRIER, Martin
dc.contributor.authorMOREL, Jacques
dc.contributor.authorCONSTANTIN, Arnaud
dc.contributor.authorDERNIS, Emmanuelle
dc.contributor.authorROYANT, Valerie
dc.contributor.authorSALMON, Jean-Hugues
dc.contributor.authorPHAM, Thao
dc.contributor.authorGOTTENBERG, Jacques-Eric
dc.contributor.authorPERTUISET, Edouard
dc.contributor.authorDOUGADOS, Maxime
dc.contributor.authorDEVAUCHELLE-PENSEC, Valerie
dc.contributor.authorGAUDIN, Philippe
dc.contributor.authorCORMIER, Gregoire
dc.contributor.authorGOUPILLE, Philippe
dc.contributor.authorMARIETTE, Xavier
dc.contributor.authorBERENBAUM, Francis
dc.contributor.authorALCAIX, Didier
dc.contributor.authorROUIDI, Sid Ahmed
dc.contributor.authorBERTHELOT, Jean-Marie
dc.contributor.authorMONNIER, Agnes
dc.contributor.authorPIROTH, Christine
dc.contributor.authorLIOTE, Frederic
dc.contributor.authorGOEB, Vincent
dc.contributor.authorGAUJOUX-VIALA, Cecile
dc.contributor.authorVALCKENAERE, Isabelle Chary
dc.contributor.authorHAJAGE, David
dc.contributor.authorTUBACH, Florence
dc.contributor.authorFAUTREL, Bruno
dc.date.accessioned2021-04-30T11:56:51Z
dc.date.available2021-04-30T11:56:51Z
dc.date.issued2019-06
dc.date.conference2019-06-12
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/27144
dc.language.isoENen_US
dc.title.enTowards the lowest efficacious dose (toledo): results of a multicenter non-inferiority randomized open-label controlled trial assessing tocilizumab or abatacept injection spacing in rheumatoid arthritis patients in remission
dc.typeAutre communication scientifique (congrès sans actes - poster - séminaire...)en_US
dc.subject.halSciences du Vivant [q-bio]/Immunologieen_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - U1219en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.conference.titleEULAR 2019en_US
bordeaux.countryesen_US
bordeaux.title.proceedingEULAR 2019en_US
bordeaux.conference.cityMadriden_US
bordeaux.peerReviewedouien_US
bordeaux.import.sourcehal
hal.identifierhal-02158682
hal.version1
hal.exportfalse
workflow.import.sourcehal
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.date=2019-06&rft.au=JOANNA,%20Kedra&DIEUDE,%20Philippe&MAROTTE,%20Hubert&LAFOURCADE,%20Alexandre&DUCOURAU,%20Emilie&rft.genre=conference


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée